Personally when I say leaked, maybe not the results but timing. Company could have easily sat on those hsv results until the fda clearence came through.
What better way to mask high volume than with a new FDA clearence for a new product? If sophs wanted to get in prior to results than its the perfect storm.
Free kick sophs IMO
Still only conjecture and guessing.
Ann: HSV-2 Interim Results Announcement-AHZ.AX, page-142
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$12.90 |
Change
0.200(1.57%) |
Mkt cap ! $272.6M | |||
| Open | High | Low | Value | Volume |
| $12.62 | $12.99 | $12.61 | $210.9K | 16.57K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1099 | $12.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $12.98 | 246 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |